Why targeted therapeutics have provided benefit in psoriasis: looking at IL-17 biology.

Caterina LannaSara LambiaseRuslana Gaeta ShumakCristiana BorselliTerenzio CosioAnnunziata DattolaLuca Bianchi Elena Campione

Published in: Expert review of clinical pharmacology (2022)

Il-17 inhibitors are a very fast and effective treatment against psoriasis; however, fungal infections can occur during their use, due to IL-17 biological functions. Therefore, it should be mandatory to choose the right patients to treat with these monoclonal antibodies in order to have a tailored target therapy for each patient.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
small molecule
case report
smoking cessation
drug delivery
cell wall